Ping Cai
13Patents
4h-index
42Co-inventors
60Inventor score
Filing activity: Apr 25, 2002 → Mar 29, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7445916B2 | Process for preparing rapamycin 42-esters and FK-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies | Chemistry; Metallurgy | 14 | Expired |
| US7268144B2 | Regiospecific synthesis of rapamycin 42-ester derivatives | Chemistry; Metallurgy | 12 | Expired |
| US9950058B2 | RSV F protein mutants | Chemistry; Metallurgy | 8 | Active |
| US7332601B2 | CCI-779 derivatives and methods of making same | Human Necessities | 4 | Expired |
| US7498327B2 | Indolylalkylamine metabolites as 5-hydroxytryptamine-6 ligands | Chemistry; Metallurgy | 1 | Active |
| US7625726B2 | Process for preparing rapamycin 42-esters and FK-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies | Chemistry; Metallurgy | 1 | Active |
| US10238732B2 | RSV F protein mutants | Chemistry; Metallurgy | 0 | Active |
| US7666901B2 | Analogs of 17-hydroxywortmannin as PI3K inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10233277B2 | Polymeric nanoparticles useful in theranostics | Performing Operations; Transporting | 0 | Active |
| US6914045B2 | Glycopeptide antibiotics | Human Necessities | 0 | Expired |
| US11155664B2 | Polymeric nanoparticles useful in theranostics | Performing Operations; Transporting | 0 | Active |
| US10821171B2 | RSV F protein mutants | Chemistry; Metallurgy | 0 | Active |
| US12364749B2 | RSV F protein mutants | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.